Unidad de Endocrinología Pediátrica, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Unidad de Endocrinología Pediátrica, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Endocrinol Diabetes Nutr (Engl Ed). 2023 Sep;70 Suppl 3:18-26. doi: 10.1016/j.endien.2023.07.004. Epub 2023 Aug 17.
It is recommended to periodically evaluate the health-related quality of life (HRQoL) in children and adolescents with type 1 diabetes mellitus (DM1). Despite this, no specific paediatric HRQoL instrument for DM1 has been validated in Spanish.
Multicentre, prospective descriptive study in children and adolescents with DM1 with the aim of carrying out cross-cultural adaptation to Spanish and evaluating the reliability and validity of the DISABKIDS chronic disease and diabetes-specific HRQoL questionnaires, using reverse translation.
Sociodemographic variables were compiled together with the most recent capillary glycated haemoglobin (HbA1c) value and HRQoL questionnaires were handed out to 200 Spanish children and adolescents with DM1 aged between 8 and 18 years of age under evaluation in 12 different hospitals.
The mean score on the HRQoL questionnaire (patient version) for chronic disease was 80.32 (13.66), being significantly lower (P = .04) in patients with a shorter duration of the disease (≤5 years): 78.34 (13.70) vs. 82.60 (13.36). The mean score of the DM1-specific modules was: 60.81 (16.23) for disease impact and 65.59 (26.19) for treatment impact. The mean HbA1c value was 7.08 (0.79), with no differences (P > .05) noted in the mean score of the HRQoL instruments in patients with HbA1c ≤7% vs. HbA1c >7%. The Cronbach α value varied between 0.72 and 0.90.
The Spanish versions of the DISABKIDS HRQoL instruments meet the proposed objectives of semantic equivalence and internal consistency, making it possible to periodically assess HRQoL in these patients. The good average glycaemic control presented by the patients may explain why no difference was found in the HRQoL instruments based on the HbA1c value.
建议定期评估 1 型糖尿病(DM1)患儿和青少年的健康相关生活质量(HRQoL)。尽管如此,尚未在西班牙语中验证过特定的儿科 DM1 HRQoL 工具。
对患有 DM1 的儿童和青少年进行多中心、前瞻性描述性研究,旨在进行跨文化适应西班牙文化,并使用反向翻译评估 DISABKIDS 慢性病和糖尿病特异性 HRQoL 问卷的可靠性和有效性。
收集社会人口统计学变量以及最近的毛细血管糖化血红蛋白(HbA1c)值,并向 12 家不同医院评估的 200 名年龄在 8 至 18 岁之间的西班牙 DM1 儿童和青少年分发 HRQoL 问卷。
慢性病 HRQoL 问卷(患者版)的平均得分为 80.32(13.66),疾病持续时间较短(≤5 年)的患者得分明显较低(P=0.04):78.34(13.70)比 82.60(13.36)。DM1 特异性模块的平均得分为:疾病影响 60.81(16.23),治疗影响 65.59(26.19)。平均 HbA1c 值为 7.08(0.79),HbA1c≤7%与 HbA1c>7%的患者 HRQoL 工具平均得分无差异(P>.05)。Cronbach α 值在 0.72 到 0.90 之间。
DISABKIDS HRQoL 工具的西班牙语版本符合语义等效和内部一致性的既定目标,使其能够定期评估这些患者的 HRQoL。患者的平均血糖控制良好可能解释了为什么基于 HbA1c 值的 HRQoL 工具没有差异。